1. Home
  2. VERU vs STKS Comparison

VERU vs STKS Comparison

Compare VERU & STKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Veru Inc.

VERU

Veru Inc.

HOLD

Current Price

$2.74

Market Cap

45.0M

Sector

Health Care

ML Signal

HOLD

Logo The ONE Group Hospitality Inc.

STKS

The ONE Group Hospitality Inc.

N/A

Current Price

$1.66

Market Cap

52.7M

ML Signal

N/A

Company Overview

Basic Information
Metric
VERU
STKS
Founded
1971
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
45.0M
52.7M
IPO Year
1996
2011

Fundamental Metrics

Financial Performance
Metric
VERU
STKS
Price
$2.74
$1.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$22.50
$4.70
AVG Volume (30 Days)
244.5K
20.4K
Earning Date
05-12-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$16,296,958.00
$805,722,000.00
Revenue This Year
N/A
$7.47
Revenue Next Year
N/A
$8.12
P/E Ratio
N/A
N/A
Revenue Growth
N/A
19.66
52 Week Low
$2.05
$1.63
52 Week High
$7.33
$3.38

Technical Indicators

Market Signals
Indicator
VERU
STKS
Relative Strength Index (RSI) 58.12 40.92
Support Level $2.12 $1.66
Resistance Level $2.87 $2.12
Average True Range (ATR) 0.15 0.07
MACD 0.02 -0.01
Stochastic Oscillator 75.89 17.47

Price Performance

Historical Comparison
VERU
STKS

About VERU Veru Inc.

Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.

About STKS The ONE Group Hospitality Inc.

The One Group Hospitality Inc is a restaurant company that develops, owns and operates, manages and licenses upscale and polished casual, high-energy restaurants and lounges and provides turn-key food and beverage (F&B) services for hospitality venues, including hotels, casinos, and other high-end locations internationally. The company operates through three segments: STK, Benihana and Grill Concepts. The company generates the vast majority of its revenue from the domestic market.

Share on Social Networks: